Apricus Biosciences Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Apricus Biosciences

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Strong Long	5/1/2016 3:58:06 PM
	Read Replies (1) of 2026

Eman, Aprilov I share the same appreciation as the others here. Great job! So helpful to have quality information with your assessments after the recent huge events. The fact that management has a game plan is encouraging. Nice job on cutting through some of the spin...I do like it that there are at least possible explanations for some of the recent events (Takeda - Ferring switch). As things develop, I am curious to see if management softens their stance on the "Topical" aspect of their marketing campaign, and moves on to perhaps an application that penetrates the meatus marginally, to achieve a better result...if that is at all an issue (which I suspect it could be). I know that (Topical Vitaros) was a huge issue with those guiding the company, and I'm sure it still is. If Vitaros was truly topical, there would be no need to place a drop into the meatus. I don't know why it's not enough to call it the first ever cream for the treatment of ED. What matters most is that it works, bottom line! Just some thoughts... Great job guys! Happy Greek Easter James! :)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next